67 related articles for article (PubMed ID: 15736059)
1. Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line.
Tjomsland V; El-Salhy M
Histol Histopathol; 2005 Apr; 20(2):537-41. PubMed ID: 15736059
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of octreotide, galanin and serotonin on human colon cancer cells.
El-Salhy M; Starefeldt A
Oncol Rep; 2003; 10(6):1723-8. PubMed ID: 14534685
[TBL] [Abstract][Full Text] [Related]
3. Effects of triple treatment with octreotide, galanin and serotonin on a human pancreas cancer cell line in xenografts.
El-Salhy M; Tjomsland V; Theodorsson E
Histol Histopathol; 2005 Jul; 20(3):745-52. PubMed ID: 15944923
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/leukovorin on human colon cancer.
Tjomsland V; El-Salhy M
Int J Oncol; 2005 Aug; 27(2):427-32. PubMed ID: 16010424
[TBL] [Abstract][Full Text] [Related]
5. Effects of octreotide, galanin and serotonin on a human gastric cancer cell line.
El-Salhy M
Oncol Rep; 2005 May; 13(5):787-91. PubMed ID: 15809739
[TBL] [Abstract][Full Text] [Related]
6. Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer.
El-Salhy M; Hilding L; Royson H; Tjomsland V
Int J Oncol; 2005 Sep; 27(3):687-91. PubMed ID: 16077917
[TBL] [Abstract][Full Text] [Related]
7. Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line.
El-Salhy M
Oncol Rep; 2005 Jan; 13(1):45-9. PubMed ID: 15583800
[TBL] [Abstract][Full Text] [Related]
8. Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line implanted in mice: comparison between different routes of administration.
El-Salhy M
Histol Histopathol; 2005 Jan; 20(1):19-25. PubMed ID: 15578418
[TBL] [Abstract][Full Text] [Related]
9. Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer.
El-Salhy M
Curr Pharm Des; 2005; 11(16):2107-17. PubMed ID: 15974962
[TBL] [Abstract][Full Text] [Related]
10. Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma.
El-Salhy M; Sitohy B; Norrgård O
Regul Pept; 2003 Mar; 111(1-3):145-52. PubMed ID: 12609762
[TBL] [Abstract][Full Text] [Related]
11. A comparison between double and triple therapies of octreotide, galanin and serotonin on a rat colon carcinoma.
Sitohy B; El-Salhy M
Histol Histopathol; 2003 Jan; 18(1):103-10. PubMed ID: 12507289
[TBL] [Abstract][Full Text] [Related]
12. Comparison between triple therapy with octreotide, galanin and serotonin, 5-fluorouracil/leucovorin, and sequential treatment with both, on human colon cancer.
El-Salhy M
Oncol Rep; 2004 Jun; 11(6):1161-8. PubMed ID: 15138550
[TBL] [Abstract][Full Text] [Related]
13. Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts.
El-Salhy M; Dennerqvist V
Oncol Rep; 2004 Jun; 11(6):1177-82. PubMed ID: 15138552
[TBL] [Abstract][Full Text] [Related]
14. Triple therapy with octreotide, galanin and serotonin induces necrosis and increases apoptosis of a rat colon carcinoma.
El-Salhy M; Sitohy B
Regul Pept; 2002 Oct; 108(2-3):55-62. PubMed ID: 12220727
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells.
Chen W; Yoshida S; Ohara N; Matsuo H; Morizane M; Maruo T
J Clin Endocrinol Metab; 2005 Feb; 90(2):884-92. PubMed ID: 15536154
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR].
Zheng WB; Wang CH; Qiang O; Tang CW
Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550
[TBL] [Abstract][Full Text] [Related]
17. Short-term octreotide treatment induces apoptosis in human pancreatic cancer xenografts.
Zalatnai A; Bocsi J
In Vivo; 2006; 20(4):549-52. PubMed ID: 16900788
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells.
Xu Q; Takekida S; Ohara N; Chen W; Sitruk-Ware R; Johansson ED; Maruo T
J Clin Endocrinol Metab; 2005 Feb; 90(2):953-61. PubMed ID: 15572421
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
